$INZY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Inozyme Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Inozyme Pharma, Inc.. Get notifications about new insider transactions in Inozyme Pharma, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25 2021 | INZY | Inozyme Pharma, In ... | Bhagat Sarah M | Director | Option Exercise | A | 17.12 | 9,367 | 160,363 | 9,367 | |
| Jun 24 2021 | INZY | Inozyme Pharma, In ... | DIAZ REINALDO M | Director | Option Exercise | A | 17.12 | 9,367 | 160,363 | 9,367 | |
| Jun 24 2021 | INZY | Inozyme Pharma, In ... | Inozyme Pharma, Inc. | Director | Option Exercise | A | 17.12 | 9,367 | 160,363 | 9,367 | |
| Mar 25 2021 | INZY | Inozyme Pharma, In ... | Basso Stephen | SVP Finance (PFO) | Option Exercise | A | 17.77 | 13,000 | 231,010 | 13,000 | |
| Mar 17 2021 | INZY | Inozyme Pharma, In ... | Jungles Steven J | SVP, CTO | Option Exercise | A | 19.78 | 42,000 | 830,760 | 42,000 | |
| Mar 17 2021 | INZY | Inozyme Pharma, In ... | Bolte Axel | Chief Executive Off ... | Option Exercise | A | 19.78 | 117,000 | 2,314,260 | 117,000 | |
| Mar 17 2021 | INZY | Inozyme Pharma, In ... | Bjarke Henric Bjorn | SVP, COO | Option Exercise | A | 19.78 | 51,000 | 1,008,780 | 51,000 | |
| Mar 17 2021 | INZY | Inozyme Pharma, In ... | Basso Stephen | SVP Finance (PFO) | Option Exercise | A | 19.78 | 27,000 | 534,060 | 27,000 | |
| Feb 04 2021 | INZY | Inozyme Pharma, In ... | Wenkert Deborah | SVP, CMO | Option Exercise | A | 22.61 | 100,000 | 2,261,000 | 100,000 | |
| Jan 14 2021 | INZY | Inozyme Pharma, In ... | Jungles Steven J | SVP, CTO | Option Exercise | A | 2.77 | 44,315 | 122,753 | 44,315 | |
| Jan 14 2021 | INZY | Inozyme Pharma, In ... | Huertas Pedro | SVP, CMO | Option Exercise | A | 2.77 | 36,074 | 99,925 | 36,074 | |
| Jan 14 2021 | INZY | Inozyme Pharma, In ... | Bjarke Henric Bjorn | SVP, COO | Option Exercise | A | 2.77 | 51,105 | 141,561 | 51,105 | |
| Jan 14 2021 | INZY | Inozyme Pharma, In ... | Basso Stephen | SVP Finance (PFO) | Option Exercise | A | 2.77 | 41,794 | 115,769 | 41,794 | |
| Jan 14 2021 | INZY | Inozyme Pharma, In ... | Bolte Axel | Chief Executive Off ... | Option Exercise | A | 16.00 | 66,788 | 1,068,608 | 66,788 | |
| Jan 14 2021 | INZY | Inozyme Pharma, In ... | Bolte Axel | Chief Executive Off ... | Option Exercise | A | 2.77 | 159,187 | 440,948 | 159,187 | |
| Jul 29 2020 | INZY | Inozyme Pharma, In ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 1,398,600 | 0 | 0 | |
| Jul 29 2020 | INZY | Inozyme Pharma, In ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 15,000,000 | 0 | 0 | |
| Jul 29 2020 | INZY | Inozyme Pharma, In ... | Novo Holdings A/S | 10% Owner | Buy | P | 16.00 | 375,000 | 6,000,000 | 2,569,379 | 2.2 M to 2.6 M (+17.09 %) |
| Jul 29 2020 | INZY | Inozyme Pharma, In ... | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 2,194,379 | 0 | 2,194,379 | 0 to 2.2 M |
| Jul 29 2020 | INZY | Inozyme Pharma, In ... | Sanofi | 10% Owner | Option Exercise | C | 0.00 | 3,279,720 | 0 | 0 | |
| Jul 29 2020 | INZY | Inozyme Pharma, In ... | Sanofi | 10% Owner | Buy | P | 16.00 | 81,250 | 1,300,000 | 520,125 | 438.9 K to 520.1 K (+18.51 %) |
| Jul 29 2020 | INZY | Inozyme Pharma, In ... | Sanofi | 10% Owner | Buy | C | 0.00 | 438,875 | 0 | 438,875 | 0 to 438.9 K |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Option Exercise | C | 0.00 | 10,489,510 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | P | 16.00 | 600,000 | 9,600,000 | 2,003,653 | 1.4 M to 2 M (+42.75 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | C | 0.00 | 1,403,653 | 0 | 1,403,653 | 0 to 1.4 M |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Sonsini Peter W. | 10% Owner | Option Exercise | C | 0.00 | 187,156 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Sonsini Peter W. | 10% Owner | Option Exercise | C | 0.00 | 2,000,533 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Sonsini Peter W. | 10% Owner | Buy | P | 16.00 | 250,000 | 4,000,000 | 2,437,689 | 2.2 M to 2.4 M (+11.43 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Sonsini Peter W. | 10% Owner | Buy | C | 0.00 | 187,156 | 0 | 2,187,689 | 2 M to 2.2 M (+9.36 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Sonsini Peter W. | 10% Owner | Buy | C | 0.00 | 2,000,533 | 0 | 2,000,533 | 0 to 2 M |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 187,156 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 2,000,533 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | SANDELL SCOTT D | 10% Owner | Buy | P | 16.00 | 250,000 | 4,000,000 | 2,437,689 | 2.2 M to 2.4 M (+11.43 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 187,156 | 0 | 2,187,689 | 2 M to 2.2 M (+9.36 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 2,000,533 | 0 | 2,000,533 | 0 to 2 M |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | MAKOWER JOSHUA | 10% Owner | Option Exercise | C | 0.00 | 187,156 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | MAKOWER JOSHUA | 10% Owner | Option Exercise | C | 0.00 | 2,000,533 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | MAKOWER JOSHUA | 10% Owner | Buy | P | 16.00 | 250,000 | 4,000,000 | 2,437,689 | 2.2 M to 2.4 M (+11.43 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | MAKOWER JOSHUA | 10% Owner | Buy | C | 0.00 | 187,156 | 0 | 2,187,689 | 2 M to 2.2 M (+9.36 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | MAKOWER JOSHUA | 10% Owner | Buy | C | 0.00 | 2,000,533 | 0 | 2,000,533 | 0 to 2 M |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Makhzoumi Mohamad | 10% Owner | Option Exercise | C | 0.00 | 187,156 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Makhzoumi Mohamad | 10% Owner | Option Exercise | C | 0.00 | 2,000,533 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Makhzoumi Mohamad | 10% Owner | Buy | P | 16.00 | 250,000 | 4,000,000 | 2,437,689 | 2.2 M to 2.4 M (+11.43 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Makhzoumi Mohamad | 10% Owner | Buy | C | 0.00 | 187,156 | 0 | 2,187,689 | 2 M to 2.2 M (+9.36 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Makhzoumi Mohamad | 10% Owner | Buy | C | 0.00 | 2,000,533 | 0 | 2,000,533 | 0 to 2 M |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Florence Anthony A. Jr. | 10% Owner | Option Exercise | C | 0.00 | 187,156 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Florence Anthony A. Jr. | 10% Owner | Option Exercise | C | 0.00 | 2,000,533 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Florence Anthony A. Jr. | 10% Owner | Buy | P | 16.00 | 250,000 | 4,000,000 | 2,437,689 | 2.2 M to 2.4 M (+11.43 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Florence Anthony A. Jr. | 10% Owner | Buy | C | 0.00 | 187,156 | 0 | 2,187,689 | 2 M to 2.2 M (+9.36 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Florence Anthony A. Jr. | 10% Owner | Buy | C | 0.00 | 2,000,533 | 0 | 2,000,533 | 0 to 2 M |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | BASKETT FOREST | 10% Owner | Option Exercise | C | 0.00 | 187,156 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | BASKETT FOREST | 10% Owner | Option Exercise | C | 0.00 | 2,000,533 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | BASKETT FOREST | 10% Owner | Buy | P | 16.00 | 250,000 | 4,000,000 | 2,437,689 | 2.2 M to 2.4 M (+11.43 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | BASKETT FOREST | 10% Owner | Buy | C | 0.00 | 187,156 | 0 | 2,187,689 | 2 M to 2.2 M (+9.36 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | BASKETT FOREST | 10% Owner | Buy | C | 0.00 | 2,000,533 | 0 | 2,000,533 | 0 to 2 M |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | New Enterprise Associates 15, ... | 10% Owner | Option Exercise | C | 0.00 | 187,156 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | New Enterprise Associates 15, ... | 10% Owner | Option Exercise | C | 0.00 | 2,000,533 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | New Enterprise Associates 15, ... | 10% Owner | Buy | P | 16.00 | 250,000 | 4,000,000 | 2,437,689 | 2.2 M to 2.4 M (+11.43 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | New Enterprise Associates 15, ... | 10% Owner | Buy | C | 0.00 | 187,156 | 0 | 2,187,689 | 2 M to 2.2 M (+9.36 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | New Enterprise Associates 15, ... | 10% Owner | Buy | C | 0.00 | 2,000,533 | 0 | 2,000,533 | 0 to 2 M |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Longitude Capital Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 1,398,600 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Longitude Capital Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 15,000,000 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Longitude Capital Partners III ... | 10% Owner | Buy | P | 16.00 | 625,000 | 10,000,000 | 2,819,379 | 2.2 M to 2.8 M (+28.48 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Longitude Capital Partners III ... | 10% Owner | Buy | C | 0.00 | 187,154 | 0 | 2,194,379 | 2 M to 2.2 M (+9.32 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Longitude Capital Partners III ... | 10% Owner | Buy | C | 0.00 | 2,007,225 | 0 | 2,007,225 | 0 to 2 M |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Jungles Steven J | See Remarks | Option Exercise | C | 0.00 | 100,000 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Jungles Steven J | See Remarks | Buy | C | 0.00 | 13,381 | 0 | 55,417 | 42 K to 55.4 K (+31.83 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Pivotal bioVenture Partners Fu ... | 10% Owner | Option Exercise | C | 0.00 | 10,489,510 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Pivotal bioVenture Partners Fu ... | 10% Owner | Buy | P | 16.00 | 187,500 | 3,000,000 | 1,591,154 | 1.4 M to 1.6 M (+13.36 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Pivotal bioVenture Partners Fu ... | 10% Owner | Buy | C | 0.00 | 1,403,654 | 0 | 1,403,654 | 0 to 1.4 M |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Schlessinger Joseph | 10% Owner | Option Exercise | C | 0.00 | 100,000 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Schlessinger Joseph | 10% Owner | Buy | C | 0.00 | 13,381 | 0 | 286,479 | 273.1 K to 286.5 K (+4.90 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Hopfner Robert Lorne | Director | Option Exercise | C | 0.00 | 10,489,510 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Hopfner Robert Lorne | Director | Buy | P | 16.00 | 187,500 | 3,000,000 | 1,591,154 | 1.4 M to 1.6 M (+13.36 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Hopfner Robert Lorne | Director | Buy | C | 0.00 | 1,403,654 | 0 | 1,403,654 | 0 to 1.4 M |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | ALEXION PHARMACEUTICALS, INC. | 10% Owner | Option Exercise | C | 0.00 | 8,294,360 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | ALEXION PHARMACEUTICALS, INC. | 10% Owner | Buy | C | 0.00 | 1,109,910 | 0 | 1,109,910 | 0 to 1.1 M |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Sofinnova Venture Partners X, ... | 10% Owner | Option Exercise | C | 0.00 | 11,888,112 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Sofinnova Venture Partners X, ... | 10% Owner | Buy | P | 16.00 | 437,500 | 7,000,000 | 2,028,308 | 1.6 M to 2 M (+27.50 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Sofinnova Venture Partners X, ... | 10% Owner | Buy | C | 0.00 | 1,590,808 | 0 | 1,590,808 | 0 to 1.6 M |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Rock Springs Capital Managemen ... | 10% Owner | Option Exercise | C | 0.00 | 3,496,504 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | P | 16.00 | 24,000 | 384,000 | 1,067,884 | 1 M to 1.1 M (+2.30 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | P | 16.00 | 576,000 | 9,216,000 | 1,043,884 | 467.9 K to 1 M (+123.11 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | C | 0.00 | 467,884 | 0 | 467,884 | 0 to 467.9 K |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Rock Springs Capital Managemen ... | 10% Owner | Option Exercise | C | 0.00 | 3,496,504 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | P | 16.00 | 24,000 | 384,000 | 1,067,884 | 1 M to 1.1 M (+2.30 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | P | 16.00 | 576,000 | 9,216,000 | 1,043,884 | 467.9 K to 1 M (+123.11 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | C | 0.00 | 467,884 | 0 | 467,884 | 0 to 467.9 K |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Mathers Edward T | Director | Option Exercise | A | 16.00 | 9,367 | 149,872 | 9,367 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Huertas Pedro | See Remarks | Option Exercise | A | 16.00 | 43,951 | 703,216 | 43,951 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Huertas Pedro | See Remarks | Option Exercise | A | 16.00 | 43,951 | 703,216 | 43,951 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Treco Douglas A | Director | Option Exercise | A | 16.00 | 9,367 | 149,872 | 9,367 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Treco Douglas A | Director | Option Exercise | A | 16.00 | 9,367 | 149,872 | 9,367 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Edwards Martin | Director | Option Exercise | A | 16.00 | 9,367 | 149,872 | 9,367 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Edwards Martin | Director | Option Exercise | A | 16.00 | 9,367 | 149,872 | 9,367 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Bjarke Henric Bjorn | See Remarks | Option Exercise | A | 16.00 | 32,905 | 526,480 | 32,905 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Bjarke Henric Bjorn | See Remarks | Option Exercise | A | 16.00 | 32,905 | 526,480 | 32,905 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Bolte Axel | See Remarks | Option Exercise | A | 16.00 | 287,706 | 4,603,296 | 287,706 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Bolte Axel | See Remarks | Option Exercise | A | 16.00 | 287,706 | 4,603,296 | 287,706 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Hopfner Robert Lorne | Director | Option Exercise | A | 16.00 | 9,367 | 149,872 | 9,367 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Hopfner Robert Lorne | Director | Option Exercise | A | 16.00 | 9,367 | 149,872 | 9,367 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | DIAZ REINALDO M | Director | Option Exercise | A | 16.00 | 9,367 | 149,872 | 9,367 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | DIAZ REINALDO M | Director | Option Exercise | A | 16.00 | 9,367 | 149,872 | 9,367 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Sullivan Lynne Marie | Director | Option Exercise | A | 16.00 | 9,367 | 149,872 | 9,367 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Sullivan Lynne Marie | Director | Option Exercise | A | 16.00 | 9,367 | 149,872 | 9,367 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Bhagat Sarah M | Director | Option Exercise | A | 16.00 | 9,367 | 149,872 | 9,367 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Bhagat Sarah M | Director | Option Exercise | A | 16.00 | 9,367 | 149,872 | 9,367 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Basso Stephen | Senior Vice Preside ... | Option Exercise | A | 16.00 | 27,433 | 438,928 | 27,433 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Basso Stephen | Senior Vice Preside ... | Option Exercise | A | 16.00 | 27,433 | 438,928 | 27,433 |
Page: 1